Study of Multiple Doses of Saxagliptin (BMS-477118)

NCT00950599 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Saxagliptin
DRUG: Saxagliptin
DRUG: Saxagliptin
DRUG: Saxagliptin
DRUG: Saxagliptin
DRUG: Saxagliptin
DRUG: Placebo

Sponsor

AstraZeneca